Wellmarker Bio
PrivateLast Round
Series C
Aug 1, 2021
Est. Valuation
$170M
Total Funding Raised
$61.55M
Company Overview
Wellmarker Bio is a biopharmaceutical company that develops first-in-class anticancer drugs based on predictive biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wellmarker Bio Comparables
Compare Wellmarker Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ABL Bio, Inc. | 76% | |
| MedPacto, Inc. | 76% | |
| SCBIO | 74% |
Wellmarker Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 1, 2021 | ||||
| Series B | Jul 8, 2019 | ||||
| Series A | Nov 8, 2018 | ||||
| Seed | Apr 1, 2018 | ||||
| Corporate Funding | Dec 27, 2016 |
Wellmarker Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Investment Partners | Series C |
| The Wells Investment | Series A |
| Meritz Securities Co., Ltd. | Series A |
| Friend Investment Partners | Series A |
| GAIA Venture Partners | Series A |
| Sun & Tree Asset Management | Series B |
| NH Investment & Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 2678% MoM, from 72 to 2K.
- Aug 1, 2021
$12M round with participation from GTOG Private Equity and others.
Wellmarker Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Wellmarker Bio's valuation, stock price, and market status.
Is Wellmarker Bio a public or private company?
Wellmarker Bio is a private company.
What is the current stock price of Wellmarker Bio?
Wellmarker Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Wellmarker Bio worth (valuation)?
Wellmarker Bio's valuation is estimated at $170.0M based on funding round data.
Can I buy Wellmarker Bio stock?
Wellmarker Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Wellmarker Bio's last funding round?
Wellmarker Bio's most recent funding round was Series B on July 8, 2019.
Who are the main investors in Wellmarker Bio?
Key investors in Wellmarker Bio include The Wells Investment, Friend Investment Partners, NH Investment & Securities, IBK Capital, KB Securities.
Will Wellmarker Bio IPO soon?
No public IPO plans have been announced for Wellmarker Bio.
How can I track Wellmarker Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Wellmarker Bio's secondary market activity and sign up for updates.